Are there any cost saving options for tigecycline generics?

Can generics of tigecycline lower my prescription costs?
Generic tigecycline entered the U.S. market in 2021 and now sells for roughly 60–80 percent less than the original Tygacil brand. Pharmacies usually charge $35–$55 per 50 mg vial, compared with more than $200 for the brand product.

Are there further ways to reduce out-of-pocket costs?
Most Medicare Part D plans place generic tigecycline in Tier 2, keeping copays under $20. Commercial insurers often require only a $10–$25 copay once the deductible is met. Manufacturer copay cards for the brand are rarely needed once generics are stocked.

What affects price variation across pharmacies?
Retail prices fluctuate by chain and region. GoodRx coupons can bring the vial price down to about $30 at some national chains; independent pharmacies may charge $10–$15 more. Checking three nearby stores or using a price-comparison tool typically yields the lowest available rate.

When do remaining patents or exclusivities end?
The last U.S. patents listed for tigecycline expired in 2020, and no further exclusivity blocks generic entry. Additional abbreviated new drug applications are under review, which could add more suppliers and push prices lower in 2024–2025.

Can hospitals or infusion centers offer lower rates?
Hospital outpatient departments often purchase tigecycline at group-purchasing contract prices near $25 per vial and pass a portion of the discount to insured patients. Outpatient infusion centers sometimes match these rates when they dispense the drug directly.

How do biosimilar or alternative antibiotics compare?
Tigecycline has no biosimilar versions because it is a small-molecule antibiotic. Clinicians sometimes substitute generic doxycycline or minocycline when susceptibility allows, cutting daily drug cost to under $5, though spectrum coverage differs.